These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4946007)

  • 21. Chemotherapy of residual disease in solid tumours.
    Kenis Y
    Rev Eur Etud Clin Biol; 1971 Feb; 16(2):103-7. PubMed ID: 4324078
    [No Abstract]   [Full Text] [Related]  

  • 22. Indications for the treatment of cancer by regional chemotherapy.
    Westbury G; Newton KA
    Geriatrics; 1971 Nov; 26(11):122 passim. PubMed ID: 5171135
    [No Abstract]   [Full Text] [Related]  

  • 23. The current management of malignancy -- VI other solid tumors.
    Panettiere FJ
    Alaska Med; 1977 Mar; 19(2):19-25. PubMed ID: 326087
    [No Abstract]   [Full Text] [Related]  

  • 24. Phase II study of cytosine arabinoside in advanced large bowel cancer.
    Cullinan SA; O'Connell MJ; Moertel CG; Schutt AJ; Hahn RG; Reitemeier RJ; Frytak S; Rubin J
    Cancer Treat Rep; 1977 Dec; 61(9):1725-6. PubMed ID: 340037
    [No Abstract]   [Full Text] [Related]  

  • 25. Vinblastine (NSC-49842) plus vincristine (NSC-67574) given in intensive 3-day courses as therapy for lymphomas, sarcomas, and other neoplasms.
    Stolinsky DC; Bogdon DL; Pugh RP; Braunwald J; Hestorff R; Bateman JR
    Cancer Chemother Rep; 1973; 57(4):481-4. PubMed ID: 4586955
    [No Abstract]   [Full Text] [Related]  

  • 26. Phase II study of Baker's antifol in advanced colorectal cancer.
    Padilla F; Correa J; Buroker T; Vaitkevicius VK
    Cancer Treat Rep; 1978 Apr; 62(4):553-4. PubMed ID: 350391
    [No Abstract]   [Full Text] [Related]  

  • 27. Phase II trial of ifosfamide and mesna in advanced colorectal cancer.
    Kemeny N; Reichman B; Dougherty J; Lipperman R; Cheng E
    Cancer Treat Rep; 1987 Jun; 71(6):663-4. PubMed ID: 3107815
    [No Abstract]   [Full Text] [Related]  

  • 28. How to use cancer chemotherapy.
    Dollinger MR
    Am Fam Physician; 1971 Jun; 3(6):73-84. PubMed ID: 4325596
    [No Abstract]   [Full Text] [Related]  

  • 29. A clinical evaluation of a prolonged schedule of cytosine arabinoside (NSC63878).
    Burke PJ; Owens AH; Colsky J; Shnider BI; Edmonson JH; Schilling A; Brodovsky HS; Wallace HJ; Hall TC
    Cancer Res; 1970 May; 30(5):1512-5. PubMed ID: 5426952
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical experience with mitomycin C (NSC-26980).
    Whittington RM; Close HP
    Cancer Chemother Rep; 1970 Jun; 54(3):195-8. PubMed ID: 4334088
    [No Abstract]   [Full Text] [Related]  

  • 31. Effectiveness of methyl-GAG (NSC-32946) administered intramuscularly.
    Shnider BI; Colsky J; Jones R; Carbone PP
    Cancer Chemother Rep; 1974; 58(5 Pt 1):689-95. PubMed ID: 4609598
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical trials with the antitumor agent 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide(NSC-45388).
    Luce JK; Thurman WG; Isaacs BL; Talley RW
    Cancer Chemother Rep; 1970 Apr; 54(2):119-24. PubMed ID: 4334086
    [No Abstract]   [Full Text] [Related]  

  • 33. Phase II trial of iv 6-thioguanine in advanced colorectal carcinoma.
    Britell JC; Moertel CG; Kvols LK; O'Connell MJ; Rubin J; Schutt AJ
    Cancer Treat Rep; 1981; 65(9-10):909-10. PubMed ID: 7273027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II trial of maytansine in patients with advanced colorectal carcinoma.
    O'Connell MJ; Shani A; Rubin J; Moertel CG
    Cancer Treat Rep; 1978 Aug; 62(8):1237-8. PubMed ID: 356981
    [No Abstract]   [Full Text] [Related]  

  • 35. Phase II evaluation of pyrazofurin in patients with advanced colorectal carcinoma.
    Carroll DS; Kemeny NE; Gralla RJ
    Cancer Treat Rep; 1979 Jan; 63(1):139-40. PubMed ID: 369686
    [No Abstract]   [Full Text] [Related]  

  • 36. Phase II study of esorubicin in patients with advanced colorectal carcinoma and no prior chemotherapy: an Illinois Cancer Council Trial.
    Locker GY; Hoeltgen T; Kilton L; Krauss S; McNamara M; Blough R; Johnson C
    Cancer Treat Rep; 1987; 71(7-8):765-6. PubMed ID: 3300969
    [No Abstract]   [Full Text] [Related]  

  • 37. Phase II trial of 5-fluorouracil plus melphalan in colorectal carcinoma.
    Presant CA; Ratkin G; Klahr C
    Cancer Treat Rep; 1978 Mar; 62(3):461-2. PubMed ID: 348317
    [No Abstract]   [Full Text] [Related]  

  • 38. Phase II trial of esorubicin in patients with advanced colorectal carcinoma.
    Fiore J; Kemeny N; Raymond V; Young C
    Cancer Treat Rep; 1986 Oct; 70(10):1241-2. PubMed ID: 3530453
    [No Abstract]   [Full Text] [Related]  

  • 39. Phase II study of 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine in advanced colorectal carcinoma.
    Kemeny N; Yagoda A; Burchenal JH
    Cancer Treat Rep; 1978 Mar; 62(3):463-4. PubMed ID: 77190
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of Hodgkin's disease and other cancers with 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962).
    Marsh JC; DeConti RC; Hubbard SP
    Cancer Chemother Rep; 1971 Dec; 55(5):599-606. PubMed ID: 4334161
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.